Course Name Credits Type Course Format Release and expiration datesort descending
Managing Metastatic NSCLC: Strategies for Treatment Selection
  • 1.00 AMA PRA Category 1 Credit™ credit
  • 1.00 ACPE credit
  • 1.00 ANCC credit
Enduring
  • Online CME
07/12/2016 to 01/05/2018
Making Progress for Improving Patient Lives: Clinical Advances in the First-Line Treatment of Advanced Squamous Non—Small Cell Lung Cancer
  • 1.00 AMA PRA Category 1 Credit™ credit
  • 1.00 ANCC credit
  • 1.00 Attendance credit
Enduring
  • Online CME
08/23/2016 to 12/15/2017
CDK 4/6 Inhibitors: New Choices for HR-Positive, HER2-Negative Metastatic Breast Cancer
  • 1.00 AMA PRA Category 1 Credit™ credit
  • 1.00 ANCC credit
  • 1.00 Attendance credit
Enduring
  • Online CME
09/13/2016 to 05/02/2018
Paving the Way to Better Choices for Veterans With Lung Cancer: A Shared Decision-Making Approach to Treatment
  • 1.00 AMA PRA Category 1 Credit™ credit
  • 1.00 ANCC credit
  • 1.00 Attendance credit
Enduring
  • Online CME
09/20/2016 to 03/30/2018
Managing Unresectable Hepatocellular Carcinoma: Focus on Systemic Therapies
  • 1.00 AMA PRA Category 1 Credit™ credit
  • 1.00 ANCC credit
  • 1.00 Attendance credit
Enduring
  • Online CME
09/28/2016 to 02/02/2018
New Directions in Soft-Tissue Sarcomas Other Than GIST: A Focus on Sarcoma Centers
  • 1.00 AMA PRA Category 1 Credit™ credit
  • 1.00 ACPE credit
  • 1.00 ANCC credit
Enduring
  • Online CME
10/03/2016 to 10/02/2017
New Directions in Soft-Tissue Sarcomas Other Than GIST For Community Oncology Centers
  • 1.00 AMA PRA Category 1 Credit™ credit
  • 1.00 ACPE credit
  • 1.00 ANCC credit
Enduring
  • Online CME
10/03/2016 to 10/02/2017
Managing Relapsed/Refractory Myeloma in the Era of New Agents for Treatment
  • 1.00 AMA PRA Category 1 Credit™ credit
  • 1.00 ANCC credit
  • 1.00 Attendance credit
Enduring
  • Online CME
12/05/2016 to 04/10/2018
Understanding Treatment Strategies for Squamous Cell Carcinoma of the Head and Neck
  • 0.75 AMA PRA Category 1 Credit™ credits
  • 0.75 ANCC credits
  • 0.75 Attendance credits
Enduring
  • Online CME
12/13/2016 to 12/12/2017
Expanded Treatment Options for Metastatic Pancreatic Cancer: Evidence-Based Updates
  • 1.00 AMA PRA Category 1 Credit™ credit
  • 1.00 ACPE credit
  • 1.00 ANCC credit
  • 1.00 Attendance credit
Enduring
  • Online CME
12/21/2016 to 04/03/2018
Triggering the Immune System: Immune Checkpoint Inhibitors for the Treatment of Non–Small Cell Lung Cancer
  • 1.00 AMA PRA Category 1 Credit™ credit
  • 1.00 ACPE credit
  • 1.00 ANCC credit
  • 1.00 Attendance credit
Enduring
  • Online CME
12/21/2016 to 05/09/2018
The Latest Advances in CAR T-Cell Therapy for Refractory and Relapsed Lymphomas and Leukemias
  • 1.00 AMA PRA Category 1 Credit™ credit
  • 1.00 ANCC credit
  • 1.00 Attendance credit
Enduring
  • Online CME
01/06/2017 to 09/29/2017
Nursing Clinical Insights Into the Benefits and Challenges of EGFR TKIs in the Treatment of NSCLC
  • 0.50 ANCC credits
  • 0.50 Attendance credits
Enduring
  • Online CME
01/18/2017 to 01/17/2018
Current and Future Directions in the Treatment of Pulmonary Neuroendocrine Tumors
  • 1.00 AMA PRA Category 1 Credit™ credit
  • 1.00 ANCC credit
  • 1.00 Attendance credit
Enduring
  • Online CME
01/18/2017 to 05/04/2018
Incorporating CDK 4/6 Inhibitors in the Treatment of Estrogen Receptor–Positive Breast Cancer: Considerations for Nurses, Patients, and Families
  • 1.00 ANCC credit
  • 1.00 Attendance credit
Enduring
  • Online CME
02/07/2017 to 04/21/2018

Pages